Channels
All News
In Focus
Special
AI
Bioregnum
Biotech Voices
Cell/Gene Tx
China
Coronavirus
Deals
Diagnostics
Discovery
FDA+
Financing
Health Tech
Law
Letters to the Editor
Manufacturing
Marketing
Nikkei Biotechnology
Opinion
Outsourcing
Peer Review
People
Pharma
R&D
Startups
Weekly
Webinars
Biopharma Jobs
More
Work at Endpoints
Letter to Editors
Editorial Standards
IPO Tracker
Webinars
Events
Sponsored Posts
Advertise
Privacy Policy
Endpoints Merch
About Us
Help
SIGN UP
LOG IN
China channel feed
Indian CDMOs unlikely to see sudden surge in clients if China bill passes, execs say
9 months ago
Manufacturing
WuXi Biologics’ ADC spinout reports revenue jump despite Biosecure risk
9 months ago
Manufacturing
House lawmakers call on FDA to investigate clinical trials run alongside China's military
9 months ago
FDA+
BioNTech, MediLink to resume trial enrollment for HER3 antibody-drug conjugate after FDA pause
9 months ago
R&D
TYK Medicines seeks to launch new EGFR drug in China with $74M Hong Kong IPO
9 months ago
Financing
Pressure from anti-China legislation begins to ripple through biopharma
9 months ago
Pharma
Manufacturing
Merck pays $700M for clinical-stage CD3xCD19 bispecific antibody
9 months ago
Deals
Pharma
WuXi Bio gains some traction in Europe in the face of Biosecure threat in the US
9 months ago
Manufacturing
Weak China demand weighs on Illumina's sales
9 months ago
Diagnostics
Third Rock and Arie Belldegrun’s firm come together for CD20/CD3 bispecific out of China
9 months ago
Startups
Deals
Biosecure lawmakers tell trade groups that China studies are a new focus
9 months ago
Deals
China corruption crackdown hits Merck’s Gardasil sales, spooking investors
9 months ago
Pharma
WuXi AppTec sees US revenue decline amid Biosecure threat
10 months ago
Manufacturing
BeiGene plots to further build its manufacturing muscle outside of China
10 months ago
Manufacturing
Chinese biotech developing semaglutide biosimilar files for Hong Kong IPO
10 months ago
Financing
WuXi AppTec more than tripled lobbying spend as Biosecure Act advanced in Congress
10 months ago
Law
China approves Eli Lilly's weight loss drug as country launches obesity awareness campaign
10 months ago
Pharma
OrbiMed forms biotech with assets from China-based Keymed, enlists former Biohaven exec as CEO
10 months ago
Financing
Startups
Chinese drugmakers still lag in R&D depth despite outpacing Europeans in new launches
10 months ago
R&D
Pharma
House speaker plans vote on Biosecure Act as part of China legislation push
10 months ago
Pharma
As confidence falls, biopharma companies take precautions with Chinese partnerships, survey finds
10 months ago
Outsourcing
Manufacturing
Commercial-stage blood cancer biotech files for US dual listing
11 months ago
Financing
Day One enters ADC field, going after a target that once attracted AbbVie and now Genmab
11 months ago
Deals
AI drug discovery startup goes public in Hong Kong, nabbing $115M to build on pharma partnerships
11 months ago
Financing
AI
First page
Previous page
2
3
4
5
6
7
8
Next page
Last page
